Abstract
Giardia lamblia is a human intestinal pathogen. Like many protozoan microorganisms, Giardia undergoes antigenic variation, a mechanism assumed to allow parasites to evade the host's immune response, producing chronic and/or recurrent infections. Recently, we found that the mechanism controlling variant-specific surface protein (VSP) switching in Giardia involves components of the RNA interference machinery and that disruption of this pathway generates trophozoites simultaneously expressing many VSPs. Here we use these altered trophozoites to determine the role of antigenic variation in a gerbil model of giardiasis. Our results show that either primary infection with trophozoites simultaneously expressing many VSPs or immunization with purified VSPs from the transgenic cells protects gerbils from subsequent Giardia infections. These results constitute, to our knowledge, the first experimental evidence that antigenic variation is essential for parasite survival within hosts and that artificial disruption of this mechanism might be useful in generating vaccines against major pathogens that show similar behavior.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Antibodies to variable surface antigens induce antigenic variation in the intestinal parasite Giardia lamblia
Nature Communications Open Access 03 May 2023
-
Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
Nature Communications Open Access 21 January 2019
-
Vaccination of domestic animals with a novel oral vaccine prevents Giardia infections, alleviates signs of giardiasis and reduces transmission to humans
npj Vaccines Open Access 15 September 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout






References
Barrett, L.G., Thrall, P.H., Burdon, J.J. & Linde, C.C. Life history determines genetic structure and evolutionary potential of host-parasite interactions. Trends Ecol. Evol. 23, 678–685 (2008).
Vonlaufen, N., Kanzok, S.M., Wek, R.C. & Sullivan, W.J. Jr. Stress response pathways in protozoan parasites. Cell. Microbiol. 10, 2387–2399 (2008).
Zambrano-Villa, S., Rosales-Borjas, D., Carrero, J.C. & Ortiz-Ortiz, L. How protozoan parasites evade the immune response. Trends Parasitol. 18, 272–278 (2002).
Deitsch, K.W., Lukehart, S.A. & Stringer, J.R. Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens. Nat. Rev. Microbiol. 7, 493–503 (2009).
Adam, R.D. Biology of Giardia lamblia. Clin. Microbiol. Rev. 14, 447–475 (2001).
Savioli, L., Smith, H. & Thompson, A. Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'. Trends Parasitol. 22, 203–208 (2006).
Monis, P.T., Caccio, S.M. & Thompson, R.C. Variation in Giardia: towards a taxonomic revision of the genus. Trends Parasitol. 25, 93–100 (2009).
Thompson, R.C., Hopkins, R.M. & Homan, W.L. Nomenclature and genetic groupings of Giardia infecting mammals. Parasitol. Today 16, 210–213 (2000).
Luján, H.D., Mowatt, M.R. & Nash, T.E. Mechanisms of Giardia lamblia differentiation into cysts. Microbiol. Mol. Biol. Rev. 61, 294–304 (1997).
Buret, A.G. Pathophysiology of enteric infections with Giardia duodenalis. Parasite 15, 261–265 (2008).
Nash, T.E. Antigenic variation in Giardia lamblia and the host's immune response. Phil. Trans. R. Soc. Lond. B 352, 1369–1375 (1997).
Nash, T. Surface antigen variability and variation in Giardia lamblia. Parasitol. Today 8, 229–234 (1992).
Pimenta, P.F., da Silva, P.P. & Nash, T. Variant surface antigens of Giardia lamblia are associated with the presence of a thick cell coat: thin section and label fracture immunocytochemistry survey. Infect. Immun. 59, 3989–3996 (1991).
Morrison, H.G. et al. Genomic minimalism in the early diverging intestinal parasite Giardia lamblia. Science 317, 1921–1926 (2007).
Nash, T.E. Surface antigenic variation in Giardia lamblia. Mol. Microbiol. 45, 585–590 (2002).
Prucca, C.G. et al. Antigenic variation in Giardia lamblia is regulated by RNA interference. Nature 456, 750–754 (2008).
Gottstein, B. & Nash, T.E. Antigenic variation in Giardia lamblia: infection of congenitally athymic nude and scid mice. Parasite Immunol. 13, 649–659 (1991).
Nash, T.E. & Aggarwal, A. Cytotoxicity of monoclonal antibodies to a subset of Giardia isolates. J. Immunol. 136, 2628–2632 (1986).
Hemphill, A., Stager, S., Gottstein, B. & Muller, N. Electron microscopical investigation of surface alterations on Giardia lamblia trophozoites after exposure to a cytotoxic monoclonal antibody. Parasitol. Res. 82, 206–210 (1996).
Deselliers, L.P., Tan, D.T., Scott, R.B. & Olson, M.E. Effects of Giardia lamblia infection on gastrointestinal transit and contractility in Mongolian gerbils. Dig. Dis. Sci. 42, 2411–2419 (1997).
Buret, A., Hardin, J.A., Olson, M.E. & Gall, D.G. Pathophysiology of small intestinal malabsorption in gerbils infected with Giardia lamblia. Gastroenterology 103, 506–513 (1992).
Aggarwal, A. & Nash, T.E. Comparison of two antigenically distinct Giardia lamblia isolates in gerbils. Am. J. Trop. Med. Hyg. 36, 325–332 (1987).
Moss, D.M., Mathews, H.M., Visvesvara, G.S., Dickerson, J.W. & Walker, E.M. Antigenic variation of Giardia lamblia in the feces of Mongolian gerbils. J. Clin. Microbiol. 28, 254–257 (1990).
Luján, H.D., Mowatt, M.R., Conrad, J.T., Bowers, B. & Nash, T.E. Identification of a novel Giardia lamblia cyst wall protein with leucine-rich repeats. Implications for secretory granule formation and protein assembly into the cyst wall. J. Biol. Chem. 270, 29307–29313 (1995).
Nash, T.E., Herrington, D.A., Losonsky, G.A. & Levine, M.M. Experimental human infections with Giardia lamblia. J. Infect. Dis. 156, 974–984 (1987).
Mowatt, M.R., Aggarwal, A. & Nash, T.E. Carboxy-terminal sequence conservation among variant-specific surface proteins of Giardia lamblia. Mol. Biochem. Parasitol. 49, 215–227 (1991).
Luján, H.D., Mowatt, M.R., Conrad, J.T. & Nash, T.E. Increased expression of the molecular chaperone BiP/GRP78 during the differentiation of a primitive eukaryote. Biol. Cell 86, 11–18 (1996).
Gardner, T.B. & Hill, D.R. Treatment of giardiasis. Clin. Microbiol. Rev. 14, 114–128 (2001).
Upcroft, J.A., Upcroft, P. & Boreham, P.F. Drug resistance in Giardia intestinalis. Int. J. Parasitol. 20, 489–496 (1990).
Faubert, G. Immune response to Giardia duodenalis. Clin. Microbiol. Rev. 13, 35–54, (2000).
Müller, N. & von Allmen, N. Recent insights into the mucosal reactions associated with Giardia lamblia infections. Int. J. Parasitol. 35, 1339–1347 (2005).
Nash, T.E., Merritt, J.W. Jr. & Conrad, J.T. Isolate and epitope variability in susceptibility of Giardia lamblia to intestinal proteases. Infect. Immun. 59, 1334–1340 (1991).
Singer, S.M. & Nash, T.E. The role of normal flora in Giardia lamblia infections in mice. J. Infect. Dis. 181, 1510–1512 (2000).
Nash, T.E., Herrington, D.A., Levine, M.M., Conrad, J.T. & Merritt, J.W. Jr. Antigenic variation of Giardia lamblia in experimental human infections. J. Immunol. 144, 4362–4369 (1990).
Anders, R.F., Roberts-Thomson, I.C. & Mitchell, G.F. Giardiasis in mice: analysis of humoral and cellular immune responses to Giardia muris. Parasite Immunol. 4, 47–57 (1982).
Aggarwal, A. & Nash, T.E. Antigenic variation of Giardia lamblia in vivo. Infect. Immun. 56, 1420–1423 (1988).
Gottstein, B., Deplazes, P. & Tanner, I. In vitro synthesized immunoglobulin A from nu/+ and reconstituted nu/nu mice against a dominant surface antigen of Giardia lamblia. Parasitol. Res. 79, 644–648 (1993).
Stäger, S., Gottstein, B., Sager, H., Jungi, T.W. & Muller, N. Influence of antibodies in mother's milk on antigenic variation of Giardia lamblia in the murine mother-offspring model of infection. Infect. Immun. 66, 1287–1292 (1998).
Byrd, L.G., Conrad, J.T. & Nash, T.E. Giardia lamblia infections in adult mice. Infect. Immun. 62, 3583–3585 (1994).
Bouza, M., Maciques, I., Torres, D. & Nunez, F.A. Giardia lamblia in Mongolian gerbils: characteristics of infection using different human isolates. Exp. Parasitol. 96, 43–46 (2000).
Eckmann, L. Mucosal defences against Giardia. Parasite Immunol. 25, 259–270 (2003).
Ropolo, A.S., Saura, A., Carranza, P.G. & Lujan, H.D. Identification of variant-specific surface proteins in Giardia muris trophozoites. Infect. Immun. 73, 5208–5211 (2005).
Franzén, O. et al. Draft genome sequencing of Giardia intestinalis assemblage B isolate GS: is human giardiasis caused by two different species? PLoS Pathog. 5, e1000560 (2009).
Dunn, L.A., Upcroft, J.A., Fowler, E.V., Matthews, B.S. & Upcroft, P. Orally administered Giardia duodenalis extracts enhance an antigen-specific antibody response. Infect. Immun. 69, 6503–6510 (2001).
Heyworth, M.F. Relative susceptibility of Giardia muris trophozoites to killing by mouse antibodies of different isotypes. J. Parasitol. 78, 73–76 (1992).
Belosevic, M. & Faubert, G.M. Lysis and immobilization of Giardia muris trophozoites in vitro by immune serum from susceptible and resistant mice. Parasite Immunol. 9, 11–19 (1987).
Butscher, W.G. & Faubert, G.M. The therapeutic action of monoclonal antibodies against a surface glycoprotein of Giardia muris. Immunology 64, 175–180 (1988).
Hill, D.R., Burge, J.J. & Pearson, R.D. Susceptibility of Giardia lamblia trophozoites to the lethal effect of human serum. J. Immunol. 132, 2046–2052 (1984).
Olson, M.E., Ceri, H. & Morck, D.W. Giardia vaccination. Parasitol. Today 16, 213–217 (2000).
Olson, M.E., Morck, D.W. & Ceri, H. Preliminary data on the efficacy of a Giardia vaccine in puppies. Can. Vet. J. 38, 777–779 (1997).
Anderson, K.A. et al. Impact of Giardia vaccination on asymptomatic Giardia infections in dogs at a research facility. Can. Vet. J. 45, 924–930 (2004).
Uehlinger, F.D. et al. Efficacy of vaccination in preventing giardiasis in calves. Vet. Parasitol. 146, 182–188 (2007).
Mann, J.F., Acevedo, R., Campo, J.D., Perez, O. & Ferro, V.A. Delivery systems: a vaccine strategy for overcoming mucosal tolerance? Expert Rev. Vaccines 8, 103–112 (2009).
Tonkin, C.J. et al. Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum. PLoS Biol. 7, e84 (2009).
Carranza, P.G. et al. Simultaneous expression of different variant-specific surface proteins in single Giardia lamblia trophozoites during encystation. Infect. Immun. 70, 5265–5268 (2002).
Adam, R.D. et al. Antigenic variation of a cysteine-rich protein in Giardia lamblia. J. Exp. Med. 167, 109–118 (1988).
Deng, M.Y. & Cliver, D.O. Degradation of Giardia lamblia cysts in mixed human and swine wastes. Appl. Environ. Microbiol. 58, 2368–2374 (1992).
Luján, H.D., Mowatt, M.R. & Wu, J.J. Lu, Y., Lees, A., Chance M.R. & Nash T.E. Purification of a variant-specific surface protein of Giardia lamblia and characterization of its metal-binding properties. J. Biol. Chem. 270, 13807–13813 (1995).
Acknowledgements
We thank T.E. Nash (National Institute of Allergy and Infectious Diseases, US National Institutes of Health) for providing VSP-specific mAbs and Giardia strains and M.E. Rivarola and the Pathology Service of the School of Medicine, Catholic University of Cordoba, for technical assistance. This work was supported by grants from the Agencia Nacional para la Promoción de la Ciencia y la Tecnología, Consejo Nacional de Investigaciones Científicas y Técnicas, Catholic University of Cordoba, the Howard Hughes Medical Institute and the EU CONTENT Project. H.D.L. is a Howard Hughes Medical Institute International Research Scholar and a Member of the Scientific Investigator's Career of the Consejo Nacional de Investigaciones Científicas y Técnicas.
Author information
Authors and Affiliations
Contributions
F.D.R. performed most of the gerbil and in vitro experiments; C.G.P. generated transgenic trophozoites and performed confocal and epifluorescence assays; A.S. and P.G.C. collaborated in gerbil experiments and developed monoclonal antibodies. A.T. collected and evaluated human samples. All authors analyzed the data. H.D.L. supervised the project and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–5 and Supplementary Tables 1–7 (PDF 1106 kb)
Rights and permissions
About this article
Cite this article
Rivero, F., Saura, A., Prucca, C. et al. Disruption of antigenic variation is crucial for effective parasite vaccine. Nat Med 16, 551–557 (2010). https://doi.org/10.1038/nm.2141
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2141
This article is cited by
-
Antibodies to variable surface antigens induce antigenic variation in the intestinal parasite Giardia lamblia
Nature Communications (2023)
-
Giardia duodenalis Virulence — “To Be, or Not To Be”
Current Tropical Medicine Reports (2021)
-
Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
Nature Communications (2019)
-
Vaccination of domestic animals with a novel oral vaccine prevents Giardia infections, alleviates signs of giardiasis and reduces transmission to humans
npj Vaccines (2016)
-
Calling all antigens
Nature Medicine (2010)